首页> 外文期刊>JAMA: the Journal of the American Medical Association >Bile duct injury during cholecystectomy and survival in medicare beneficiaries.
【24h】

Bile duct injury during cholecystectomy and survival in medicare beneficiaries.

机译:胆囊切除术中的胆管损伤和医疗保险受益人的生存率。

获取原文
获取原文并翻译 | 示例
           

摘要

CONTEXT: Common bile duct (CBD) injury during cholecystectomy is a significant source of patient morbidity, but its impact on survival is unclear. OBJECTIVE: To demonstrate the relation between CBD injury and survival and to identify the factors associated with improved survival among Medicare beneficiaries. DESIGN, SETTING, AND PATIENTS: Retrospective study using Medicare National Claims History Part B data (January 1, 1992, through December 31, 1999) linked to death records and to the American Medical Association's (AMA's) Physician Masterfile. Records with a procedure code for cholecystectomy were reviewed and those with an additional procedure code for repair of the CBD within 365 days were defined as having a CBD injury. MAIN OUTCOME MEASURE: Survival after cholecystectomy, controlling for patient (sex, age, comorbidity index, disease severity) and surgeon (procedure year, case order, surgeon specialty) characteristics. RESULTS: Of the 1 570 361 patients identified as having had a cholecystectomy (62.9% women), 7911 patients (0.5%) had CBD injuries. The entire population had a mean (SD) age of 71.4 (10.2) years. Thirty-three percent of all patients died within the 9.2-year follow-up period (median survival, 5.6 years; interquartile range, 3.2-7.4 years), with 55.2% of patients without and 19.5% with a CBD injury remained alive. The adjusted hazard ratio (HR) for death during the follow-up period was significantly higher (2.79; 95% confidence interval [CI]; 2.71-2.88) for patients with a CBD injury than those without CBD injury. The hazard significantly increased with advancing age and comorbidities and decreased with the experience of the repairing surgeon. The adjusted hazard of death during the follow-up period was 11% greater (HR, 1.11; 95% CI, 1.02-1.20) if the repairing surgeon was the same as the injuring surgeon. CONCLUSIONS: The association between CBD injury during cholecystectomy and survival among Medicare beneficiaries is stronger than suggested by previous reports. Referring patients withCBD injuries to surgeons or institutions with greater experience in CBD repair may represent a system-level opportunity to improve outcome.
机译:背景:胆囊切除术中胆总管(CBD)损伤是患者发病的重要原因,但其对生存的影响尚不清楚。目的:证明CBD损伤与生存之间的关系,并确定与Medicare受益人生存改善相关的因素。设计,地点和患者:使用Medicare国家索赔历史记录B部分数据(1992年1月1日至1999年12月31日)的回顾性研究,该数据与死亡记录和美国医学会(AMA)的医生主文件相关联。对具有胆囊切除术程序代码的记录进行了审查,而在365天之内具有修复CBD的其他程序代码的记录被定义为患有CBD损伤。主要观察指标:胆囊切除术后生存,控制患者(性别,年龄,合并症指数,疾病严重程度)和外科医生(手术年份,病例顺序,外科医生专长)的特征。结果:在确定为进行了胆囊切除术的1 570 361例患者中(女性占62.9%),有7911例患者(0.5%)患有CBD损伤。整个人口的平均(SD)年龄为71.4(10.2)岁。在9.2年的随访期内,所有患者中有33%死亡(中位生存期5.6年;四分位间距为3.2-7.4年),其中55.2%的患者没有死亡,而19.5%的CBD损伤仍然存活。随访期间,CBD损伤患者的调整后死亡危险比(HR)显着高于无CBD损伤的患者(2.79; 95%置信区间[CI]; 2.71-2.88)。危险随着年龄和合并症的增加而显着增加,而随着修复医生的经验而降低。如果修复外科医师与受伤外科医师相同,则在随访期间调整后的死亡危险要大11%(HR,1.11; 95%CI,1.02-1.20)。结论:胆囊切除术中CBD损伤与Medicare受益人的生存之间的关联比以前的报告更强。将CBD受伤的患者转诊至具有CBD修复经验的医生或机构可能代表改善结果的系统级机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号